EP 0825872 A1 19980304 - PHARMACEUTICAL ADMINISTRATION FORM OF PARATHYROID HORMONE HAVING AN ACTIVE INGREDIENT RELEASE PERIOD OF FROM TWO TO SIX HOURS
Title (en)
PHARMACEUTICAL ADMINISTRATION FORM OF PARATHYROID HORMONE HAVING AN ACTIVE INGREDIENT RELEASE PERIOD OF FROM TWO TO SIX HOURS
Title (de)
PAEATHORMON PHARMAZEUTISCHE DARREICHUNGSFORM MIT EINER WIRKSTOFFFREISETZUNGSPERIODE VON ZWEI BIS SECHS STUNDEN
Title (fr)
FORME D'ADMINISTRATION PHARMACEUTIQUE D'HORMONE PARATHYROIDIENNE AYANT UNE PERIODE DE LIBERATION DE L'INGREDIENT ACTIF DE DEUX A SIX HEURES
Publication
Application
Priority
- DE 19517430 A 19950512
- EP 9601962 W 19960509
Abstract (en)
[origin: WO9635447A1] The present invention is directed to a pharmaceutical administration form of parathyroid hormone or parathyroid hormone derivatives having an active ingredient release period of from two to six hours, the use of parathyroid hormone for the preparation of such pharmaceutical administration forms, and to a method for treating osteoporosis in the human body.
IPC 1-7
IPC 8 full level
A61K 9/00 (2006.01); A61K 9/52 (2006.01); A61K 38/00 (2006.01); A61K 38/22 (2006.01); A61K 38/29 (2006.01); A61P 3/02 (2006.01); A61P 3/14 (2006.01); A61P 19/10 (2006.01); A61P 43/00 (2006.01); C07K 14/51 (2006.01)
CPC (source: EP)
A61K 9/0009 (2013.01); A61K 38/29 (2013.01); A61P 3/02 (2017.12); A61P 3/14 (2017.12); A61P 19/10 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 9635447A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9635447 A1 19961114; AU 5816596 A 19961129; DE 19517430 A1 19961114; EP 0825872 A1 19980304; IL 118202 A0 19960912; JP H11505222 A 19990518; ZA 963714 B 19971110
DOCDB simple family (application)
EP 9601962 W 19960509; AU 5816596 A 19960509; DE 19517430 A 19950512; EP 96919738 A 19960509; IL 11820296 A 19960509; JP 53376296 A 19960509; ZA 963714 A 19960510